From: Tracking cancer progression: from circulating tumor cells to metastasis
Molecular type | Technology | Outcome | Advantages | Limitations | Key references |
---|---|---|---|---|---|
Genome | FISH | • CNA | • Reduced experimental time • Reduced cost • Allows spatial information | • Limited number of genes | |
Targeted DNA sequencing | • Point mutations from a small to a moderate set of genes | • High sensitivity • Reduced cost | • Limited number of genes | De Luca et al. [29] | |
Single-cell exome sequencing | • CNA • Point mutations from exome regions | • Comprehensive profiling in exon regions | • WGA required • High dropout levels | ||
Single-cell whole-genome sequencing | • CNA • DNA rearrangements • Point mutations | • Comprehensive profiling of the genome | • WGA required • False-positive errors introduced during WGA • High allele dropout levels • Non-uniform coverage • Allelic imbalance introduced during WGA | ||
Transcriptome | qRT-PCR | • Expression level of a moderate set of genes | • High sensitivity for genes expressed at low levels • Reduced experimental time • Reduced cost | • Limited number of transcripts • Requires pre-amplification of targeted cDNA | Gorges et al. [33] |
RNA in situ hybridization | • Expression level of a set of genes | • High sensitivity for genes expressed at low levels • Allows targeted or comprehensive profiling • Reduced experimental time • Allows spatial information • Reduced cost | • Limited to transcripts that are included in the probe design | ||
Single-cell RNA sequencing | • Whole-transcriptome expression • CNA • Point mutations from cDNA regions | • Comprehensive profiling • Allows alternative splicing analysis • Allows discovery of new annotated transcripts | • Low success rate of WTA • Amplification bias introduced during WTA • Low sensitivity for transcripts with low abundance | ||
Epigenome | Targeted | • Epigenetic marks | • High sensitivity • Reduced cost • Reduced experimental time | • Limited number of genes | Pixberg et al. [39] |
Whole-genome bisulfite sequencing | • Epigenetic marks from the whole genome | • Comprehensive profiling | • WGA required • High dropout levels | Gkountela et al. [40] | |
ATAC-seq | • Chromatin accessibility | • Comprehensive profiling | • Low coverage data • High dropout levels | Klotz et al. [41] | |
Proteome | Immunostaining | • Protein levels of a small set of targets | • Reduced cost • Reduced experimental time | • Limited number of proteins • Relies on antibody specificity and proper controls | Paoletti et al. [42] |
Single-cell western blot | • Up to eight different targets | • High specificity • Reduced cost • Reduced experimental time | • Limited number of proteins | Sinkala et al. [43] | |
Single-cell mass cytometry | • Up to 40 different targets | • Reduced cost • Reduced experimental time | • Limited number of proteins | Gerdtsson et al. [44] | |
Bulk mass spectroscopy | • Whole proteome levels | • Comprehensive profiling | • Limited number of proteins • Low sensitivity for features with low abundance | Jordan et al. [45] | |
Single-cell mass spectroscopy | • Whole proteome levels | • Comprehensive profiling | • Not well established yet | Abouleila et al. [19] | |
Single-cell multi-omics | Genome and transcriptome | • CNA • DNA rearrangements • Point mutations from the whole genome or exome regions • Whole-transcriptome expression | • Allows quantitative trait loci analysis | • Yields lower quality data compared to individual protocols | Szczerba et al. [46] |